• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Linear 1,3-diarylpropanoids Retro-dihydrochalcones
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Linear 1,3-diarylpropanoids Chalcones and dihydrochalcones Retro-dihydrochalcones

Chemical Profile of 1-(2-fluorophenyl)-3-(4-methylphenyl)propan-1-one (CAS No. 898768-97-3)

1-(2-fluorophenyl)-3-(4-methylphenyl)propan-1-one, identified by its Chemical Abstracts Service number 898768-97-3, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This molecule, featuring a unique structural arrangement of a fluorinated phenyl ring and a methylphenyl substituent on a propanone backbone, has garnered attention due to its potential applications in drug discovery and synthetic organic chemistry. The presence of a fluorine atom at the 2-position of the phenyl ring introduces electronic and steric effects that can modulate the biological activity of the molecule, making it a subject of interest for medicinal chemists.

The compound's structure, characterized by a 1-(2-fluorophenyl)-3-(4-methylphenyl)propan-1-one framework, suggests potential interactions with biological targets such as enzymes and receptors. The fluorine atom is known to enhance metabolic stability and binding affinity in many drug molecules, while the methyl group at the 4-position of the second phenyl ring may influence the molecule's solubility and pharmacokinetic properties. These features make it a valuable scaffold for designing novel therapeutic agents.

In recent years, there has been growing interest in the development of fluorinated aromatic compounds due to their diverse biological activities. Studies have shown that fluorine substitution can significantly alter the pharmacological profile of molecules, often leading to improved efficacy and reduced toxicity. The 1-(2-fluorophenyl)-3-(4-methylphenyl)propan-1-one structure exemplifies this trend, with its potential to serve as a precursor for various pharmacologically active compounds.

Research in the field of medicinal chemistry has demonstrated that molecules with similar structural motifs can exhibit properties relevant to neurological disorders, inflammation, and cancer. For instance, studies on fluorinated phenethylamines have revealed their potential as dopaminergic agents, while analogous structures have been explored for their anti-inflammatory and anticancer activities. The 1-(2-fluorophenyl)-3-(4-methylphenyl)propan-1-one compound, with its dual phenyl ring system and fluorine substitution, may share some of these properties, making it a promising candidate for further investigation.

The synthesis of 1-(2-fluorophenyl)-3-(4-methylphenyl)propan-1-one involves multi-step organic transformations that highlight the versatility of modern synthetic methodologies. Key steps typically include Friedel-Crafts acylation followed by nucleophilic substitution or condensation reactions to introduce the necessary substituents. The use of advanced catalytic systems has enabled more efficient and sustainable synthetic routes, reducing waste and improving yields. These advancements are crucial for scaling up production and making such compounds more accessible for research purposes.

From a computational chemistry perspective, the 1-(2-fluorophenyl)-3-(4-methylphenyl)propan-1-one molecule can be extensively studied using molecular modeling techniques. These studies help in understanding its interactions with biological targets at the atomic level, guiding the design of more effective derivatives. Techniques such as docking simulations and quantum mechanical calculations have been instrumental in predicting binding affinities and metabolic stability, thereby accelerating the drug discovery process.

The pharmaceutical industry continues to leverage fluorinated compounds due to their favorable pharmacokinetic profiles. The 1-(2-fluorophenyl)-3-(4-methylphenyl)propan-1-one structure aligns well with this trend, offering a balance between potency and selectivity. As research progresses, new applications for this compound are likely to emerge, particularly in areas where fluorine substitution plays a critical role in drug design.

In conclusion, 1-(2-fluorophenyl)-3-(4-methylphenyl)propan-1-one (CAS No. 898768-97-3) represents an intriguing compound with significant potential in pharmaceutical research. Its unique structural features and reported biological activities make it a valuable scaffold for developing novel therapeutic agents. With ongoing advancements in synthetic chemistry and computational methods, further exploration of this molecule is warranted to uncover its full potential in medicine.

• 85068-30-0(2',4'-Difluoropropiophenone)
• 29112-90-1(2',5'-Difluoropropiophenone)
• 111982-45-7(2-FLUOROPHENYL CYCLOPENTYL KETONE)
• 446-22-0(2-Fluoropropiophenone)
• 220141-69-5(2',4',6'-Trifluoropropiophenone)
• 85068-31-1(2',6'-Difluoropropiophenone)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)